We evaluated the new, fully automated molecular BD Max methicillin-resistant 
Staphylococcus aureus (MRSA) assay for detection of methicillin-resistant S. 
aureus in a low-prevalence (4.1%) setting. Sensitivity, specificity, and 
positive and negative predictive values were 93.9%, 99.2%, 83.8%, and 99.7%, 
respectively. The assay reported fewer unresolved results than the BD GeneOhm 
MRSA ACP assay.